Please provide your email address to receive an email when new articles are posted on . Risk and annualized rate of severe exacerbations dropped with as-needed use of albuterol-budesonide vs.

Please provide your email address to receive an email when new articles are posted on . Patients had mild asthma and uncontrolled symptoms. Doses included an albuterol-budesonide combination or ...

The Food and Drug Administration recently approved Amphastar’s albuterol sulfate inhalation aerosol, previously known as AMP-008. This product is for the treatment or prevention of bronchospasm in ...